20-50% success rate seems worth a try. Or not?
Frew (2006) is one of the larger trials, two treatments, one group worked up to dosage of 10k, the other 100k. Higher dosage group had better measures of improvement across the board (excluding lung symptoms oddly), table III.
https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/16461133/
There's also the Cochrane review
https://sci-hub.se/https://www.cochranelibrary.com/cdsr/doi/...